{"name":"Sun Pharma Advanced Research Company Limited","slug":"sun-pharma-advanced-research-company-limited","ticker":"","exchange":"","domain":"sparc.life","description":"","hq":"Mumbai","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"immunology","drugs":[{"name":"SPARC1104 modified dose regimen II","genericName":"SPARC1104 modified dose regimen II","slug":"sparc1104-modified-dose-regimen-ii","indication":"Undisclosed indication","status":"phase_3"},{"name":"Placebo0921","genericName":"Placebo0921","slug":"placebo0921","indication":"Other","status":"phase_3"},{"name":"Reference001 type I","genericName":"Reference001 type I","slug":"reference001-type-i","indication":"Other","status":"phase_1"},{"name":"SPARC001 type I","genericName":"SPARC001 type I","slug":"sparc001-type-i","indication":"Other","status":"phase_1"},{"name":"SPARC0913","genericName":"SPARC0913","slug":"sparc0913","indication":"Phase 3 clinical trials are ongoing for SPARC0913 in various indications.","status":"phase_3"},{"name":"SPARC1104 modified dose regimen III","genericName":"SPARC1104 modified dose regimen III","slug":"sparc1104-modified-dose-regimen-iii","indication":"Other","status":"phase_3"},{"name":"SPARC1613","genericName":"SPARC1613","slug":"sparc1613","indication":"Other","status":"phase_1"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"SPARC1104 modified dose regimen I","genericName":"SPARC1104 modified dose regimen I","slug":"sparc1104-modified-dose-regimen-i","indication":"Non-small cell lung cancer, PD-L1 positive","status":"phase_3"},{"name":"Reference0912","genericName":"Reference0912","slug":"reference0912","indication":"Non-small cell lung cancer, PD-L1 positive","status":"phase_3"},{"name":"SPARC0912","genericName":"SPARC0912","slug":"sparc0912","indication":"Peripheral T-cell lymphoma (PTCL)","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"SDN-037","genericName":"SDN-037","slug":"sdn-037","indication":"Type 2 diabetes","status":"phase_3"},{"name":"SPARC0921","genericName":"SPARC0921","slug":"sparc0921","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"SPARC1104 modified dose regimen I","genericName":"SPARC1104 modified dose regimen I","slug":"sparc1104-modified-dose-regimen-i","phase":"phase_3","mechanism":"SPARC1104 modified dose regimen I is a drug that targets the PD-1/PD-L1 pathway.","indications":["Non-small cell lung cancer, PD-L1 positive"],"catalyst":""},{"name":"SPARC1104 modified dose regimen II","genericName":"SPARC1104 modified dose regimen II","slug":"sparc1104-modified-dose-regimen-ii","phase":"phase_3","mechanism":"SPARC1104 is a modified dose regimen of an undisclosed drug, but it is likely a small molecule targeting a specific molecular pathway.","indications":["Undisclosed indication"],"catalyst":""},{"name":"Placebo0921","genericName":"Placebo0921","slug":"placebo0921","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Reference001 type I","genericName":"Reference001 type I","slug":"reference001-type-i","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Reference0912","genericName":"Reference0912","slug":"reference0912","phase":"phase_3","mechanism":"Reference0912 is a drug that targets the PD-1 receptor.","indications":["Non-small cell lung cancer, PD-L1 positive"],"catalyst":""},{"name":"SDN-037","genericName":"SDN-037","slug":"sdn-037","phase":"phase_3","mechanism":"SDN-037 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"SPARC001 type I","genericName":"SPARC001 type I","slug":"sparc001-type-i","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC0912","genericName":"SPARC0912","slug":"sparc0912","phase":"phase_3","mechanism":"SPARC0912 is a selective inhibitor of histone deacetylase (HDAC) that promotes acetylation of histones and non-histone proteins to modulate gene expression and induce anti-tumor effects.","indications":["Peripheral T-cell lymphoma (PTCL)","Cutaneous T-cell lymphoma (CTCL)"],"catalyst":""},{"name":"SPARC0913","genericName":"SPARC0913","slug":"sparc0913","phase":"phase_3","mechanism":"SPARC0913 is a small molecule that targets the molecular target.","indications":["Phase 3 clinical trials are ongoing for SPARC0913 in various indications."],"catalyst":""},{"name":"SPARC0921","genericName":"SPARC0921","slug":"sparc0921","phase":"phase_3","mechanism":"SPARC0921 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"SPARC1104 modified dose regimen III","genericName":"SPARC1104 modified dose regimen III","slug":"sparc1104-modified-dose-regimen-iii","phase":"phase_3","mechanism":"SPARC1104 is a modified dose regimen of an undisclosed compound, details of which are not publicly available.","indications":[],"catalyst":""},{"name":"SPARC1613","genericName":"SPARC1613","slug":"sparc1613","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNdTl0WHgzdy1Pd2p4eUFqbE5odEZFREZWNm1CRDlid2xaQVcxa2ZLV244N0N4WElIb19Wc05lTFJ3OWtCS3dJVVFpUFBTaGVibm8tZkstSjVQOFUyZm9yVmNPdDdQUzlGWGRxYTVzdGxMeUhraU9yYThwekdMMFVXb0l5ZDc1YVgxRWtHTGtlUGZadHJNeGRnYlp4QW9NMG5QS1JZY191dU1xM1hHUC13REk0UnJfMGxyV3NQQW5aSWtQWF9DWmFNWUFpWQ?oc=5","date":"2026-04-08","type":"pipeline","source":"Markets Mojo","summary":"Sun Pharma Advanced Research Company Ltd Surges 8.2% to D... - Markets Mojo","headline":"Sun Pharma Advanced Research Company Ltd Surges 8.2% to D...","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxOcTVNRkpBcnRaMXZZZFhmY3JtSnU2bzRhX0xoMXVFRndjeVVvako0UVZFZWZzc18yLVlQQ0xjVWVvekN3YXdxbVphSUtKT1k5N1EzMWwzTVMwdXZSenh5SjhXdG5kaWctdlR5dW9VZGpKN3hCZDBzS09iVXFRUk9SNmJNQnBFZ0NkYWNjbUJYcFhqS0I0cm9nMXhHcTZYa2dBbnJMM3FRNkY5aV9YN1J3cUpCQTQ5MWpHVDN4UWF4elI0SkFxYjM0V0VmcWNORGNqVTZjbm1ZTG1kV1Q2RG1paHoxSmREQQ?oc=5","date":"2026-04-08","type":"pipeline","source":"Markets Mojo","summary":"Sun Pharma Advanced Research Company Ltd Opens 6.26% Higher Amid Mixed Technical Signals - Markets Mojo","headline":"Sun Pharma Advanced Research Company Ltd Opens 6.26% Higher Amid Mixed Technical Signals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxNSEZwSUNsR0x4a1ZkNmRNVklJdVJXTlpXbW1NTkFmSHpwZzZIb2h0OUplUXFFMjNzZ0I1ek9jZHBrOGY5SnJ5cDlXTGZYUTFOVk9HUkRUQWh0RVZWUTlweC1LZW9fVWZ0T3pycEJjTm5TZ3diNXFxQjlhZEZHY3h1Slo4c1VLSDRQRDBzbGVSTW5fTy1zVmluY1g0WWdsSzJ4QjdMTk9pY2psRi1CMV90RlhxVUszekNUUEFOc2tfQURYMUktb0JReC1YUlRYdlFMckc3VktmQUdZdw?oc=5","date":"2026-04-06","type":"earnings","source":"scanx.trade","summary":"Sun Pharmaceutical Industries Files Q4FY26 Depository Compliance Certificate - scanx.trade","headline":"Sun Pharmaceutical Industries Files Q4FY26 Depository Compliance Certificate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNQWN2bThxaWFjd2FSUURBV2RaU1BURWMtSGd6cE9CQVdmUy1DMkFYam1INmh4SWhNYUp1TXVxWWlCRjRNdl9oSm95ZElmMVV2UGtYMU9ab2loV2o2ODNpREhqWmxBbVFGM2lhN3ZSRjdFSjNCSUpJaUE3dDRWcTBKNDRfbzBCOF9uVEgxc2J5NjIzNC1pcDBfbHZxVUw1dUNJYWY3NWdiWlMtUVdRX0NITzB2ay1xMkE3b3dvN1kwTFMycC15NjBrSmVkV19nX2pOaEFfc3FTQ1FJazdmTnc?oc=5","date":"2026-04-05","type":"pipeline","source":"Markets Mojo","summary":"Sun Pharma Advanced Research Company Ltd Faces Bearish Momentum Amid Technical Downturn - Markets Mojo","headline":"Sun Pharma Advanced Research Company Ltd Faces Bearish Momentum Amid Technical Downturn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQTTJYNzMyZFNMY1JHZmttS1djRjI3TlloUm9sVjFzUEFBRG5SOTg3RWZ6NUhpdFdlSHFXT1hCNnpDOWpnamdBX24yMUl6dWo4aFY4WHd4TmJIdmFlVWF6S0xnS2poOHhXS202NGlYUy1HUkllVWhNaHZab2dCQk9McmhRNDNEa1V3OGNQVXJLeVh2MHRoc09Kb1NXVXJzYmc3NUZHcF8xeldudDNHVklhLXAzaTFuY3VZNlJrbWxpRXJQTzZwUExRbThsMDF1ejFyeWpjS3QtZDE?oc=5","date":"2026-04-03","type":"pipeline","source":"scanx.trade","summary":"Sun Pharma Advanced Research Company Limited Announces Senior Management Resignation - scanx.trade","headline":"Sun Pharma Advanced Research Company Limited Announces Senior Management Resignation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNUDdUdWZyZGZOWnpITmNqWW9WZkc3TFcwQXA0YzBWUkw0b2xaSWtfUmt6YXlSU2NMNmNfTlRpTzM5d21McGs2dTQyN3I3dXJRd01EUGYwak1CZ0xVblRqdzhFS2F6a1htUXRDSF81akhrcnlIYWZ0QjlyQk13VUp5RjQtal9sd2syQzVDUTI3ZlNZSGVveDZxZkhuTXRwMUZWR2M5ODJTTFd3N0JsSWNrMzRfNzJMN1dnUHl0SVJLV0ZXSm13?oc=5","date":"2026-03-27","type":"pipeline","source":"marketscreener.com","summary":"Sun Pharma Advanced Research Company Limited Announces Management Changes - marketscreener.com","headline":"Sun Pharma Advanced Research Company Limited Announces Management Changes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOTlFrNkdKMERxN2c2dU90NldDWXU3Q0JnYXhyVFIzWFJMbkxwME5wemozSkp0UnYycXpnZmVzOFNuaC1sdExXUVRGd3FqUmt2OE5KcU9CbmdlTmFyN2xqQVExZnR5SEhrV0doYThLSm03OTJLSWVzRGJMVnRSZnlvbVFZQS1lOFJHN1ZmOEJISml1ZTIxUUg2YmFiTVlxMFVUd1N0S3JNQ1Y2b0lxU0ZOWjVzVm94WE9nMUdSZUVnZGs4V0ZtcTBya2lzbHBUNjNXX1FHaHJTQ1d4d1c0?oc=5","date":"2026-03-27","type":"pipeline","source":"scanx.trade","summary":"Sun Pharma Advanced Research Company Responds to BSE Inquiry on Trading Volume Increase - scanx.trade","headline":"Sun Pharma Advanced Research Company Responds to BSE Inquiry on Trading Volume Increase","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-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?oc=5","date":"2026-02-04","type":"pipeline","source":"simplywall.st","summary":"Investors in Sun Pharma Advanced Research (NSE:SPARC) from three years ago are still down 26%, even after 13% gain this past week - simplywall.st","headline":"Investors in Sun Pharma Advanced Research (NSE:SPARC) from three years ago are still down 26%, even after 13% gain this ","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-09","type":"pipeline","source":"Medical Dialogues","summary":"Amid Debt Pressure, Sun Pharma's Research Arm SPARC Plans 40% Workforce Reduction - Medical Dialogues","headline":"Amid Debt Pressure, Sun Pharma's Research Arm SPARC Plans 40% Workforce Reduction","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxOMVFhR3pVZUNpLUtwR3I5N0xYbEp3UllYVlk3TkhVSURzVDN0QXY2UnlvNUVKTGpmNGxSZnR5amJ1Snh6RHR0dGtzTS1lNnVORHFBOHZvMm5hY0JtdGRQQldlaW1QbE8wYXNpQ1h1RG5xd2VRYUR1OF9BdFREeXE4ZndQT1FKZW51cHBvNC1PQl9SZ0Z5ZnBaM3RaV210LXhvX1FFSFU4cGtzYmc0WGdKWDVUXzBSV2dlTVVvbW4tTWtFRl9jQVp3NFlaSjllM2R60gHWAUFVX3lxTE1pT3JRcHVrVFFmcS1ZNnI2bjZrOGl6ZDE5YWdxc19vNEFiTFMzMXMxNXNPdEE3aVRQYVVma096TjJSNWIyM0tHcDNYV1ZkaXRBVmRqRHlHSFE1VlIyMVlmdkd1LUxGSm5vVE80Mmp0U1ZaSXFGSHlzSWs1ZmtubEMxdms4Tkd5TXpQNGJxYlJYWV9XaGdUa1R1T3g4SzlxQ3I2WXhBdDZJVFBnaXBTVHg3aVFNX0VIVV95Uzc3NUVZdVZoS2p0SnJYbGZOeXZIU2tYTjRsMUE?oc=5","date":"2026-01-08","type":"pipeline","source":"ET Pharma","summary":"Sun Pharma Advanced Research to trim workforce by 40% - ET Pharma","headline":"Sun Pharma Advanced Research to trim workforce by 40%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNQlE4OUx0ZmNOcXc1cTRMd000N2RHSGpRY3g1dFVzUjk1VWljQjNrWVJqdG9KalRET0xEd0VQMEQzTllUNmVVVEdIcktYUVI3bEttVFVfS0FtTGdsNGpJMjZmUHRncVRieGF1bkhBS05VV2JDa1lTaVVfcG5raTY2TW5yWDJnRDdKQ01sREVVcFhJZGhYRkdxalJWX0NmblYzU1JnekF6ekNhV29UdmtTZGRyaktZZkYwMlNvVVdzekFsMFdZZ3RBYkw2dmJOVnpyWWJqOURxaE8?oc=5","date":"2025-12-04","type":"pipeline","source":"meyka.com","summary":"Sun Pharma Advanced Research Company Limited (SPARC.BO): Analyzing Recent Market Volatility and Technical Indicators - meyka.com","headline":"Sun Pharma Advanced Research Company Limited (SPARC.BO): Analyzing Recent Market Volatility and Technical Indicators","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxQczJvSE02NjlkUHdoMUtDZGJSalJaSlF6QUZzZkxjTU5Ca3RGRTBYSkJJY1NyWlJaaG4zWEJJUDYyWUsyYVVkaV9oMnluWjAwVWRGUzZVNE9tTjdEc0NNdV9nZ1JiUjFYQ3BrZjJqLWgyTFBtZnUwVXdNaHY5WTdCY0dWV1JqWEdKS085cnQtd2Qzak9VNEFhSTFoYUpWeVJJUFRJQ1FWcUY4Rlo1dmt5NEdlOURjTlVMR0p0TV92ZWwtZzk2SVE1cm9HMmhLb0dJeUU1RnhtZjFEREtNOFJmZFJ6NEJoTnRJTVRrMUhtdXY2OW9DNGUwTTF2MNIBgAJBVV95cUxQX1FTSG9Ndm5Va01TcVNFRWdTRXJER1l1SzQtM1NDS2RCZUJ1NVRMOExWeEhTLXdJSmt5YUZLc3lpX2FiaFlhRGY0dEJsOFRJXzNMNkRkdXl4ZW9yRE9ocDVsbjJzNXM5Qjc4RzRLb01GNmd1QmQ4YTZZaks3R0E4Tm52Vl9DRzE0MDN6WTFzMVR0NmMwMmQ3TUcyQjRLWVNHZUVsU0g1M2pNc3M1LWp0Qkw3TVpsQ3lxZ3JKbFRLWHlidUl6TzdjTF9naXRwNTFWOEsyeTQ2WHdaWURIR2tRa1RjY0ZWMUx6RV93REJiazA2enM3REpKcDdVR1M1LTNP?oc=5","date":"2025-12-03","type":"earnings","source":"simplywall.st","summary":"Sun Pharma Advanced Research Company Limited (NSE:SPARC) surges 21%; private companies who own 46% shares profited along with insiders - simplywall.st","headline":"Sun Pharma Advanced Research Company Limited (NSE:SPARC) surges 21%; private companies who own 46% shares profited along","sentiment":"positive"}],"patents":[],"drugCount":12,"phaseCounts":{"phase_3":9,"phase_1":3},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}